BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  Pentixapharm Announces IND Submission to FDA for Phase 3 PANDA Study of First-in-Class CXCR4-Targeted Cardiovascular Diagnostic

  May 11, 2026

   · 

  6 min read
• Press Releases

  Daiichi Sankyo Unveils New Five-Year Business Plan Focused on Oncology Leadership and Innovation

  May 11, 2026

   · 

  5 min read
• Press Releases

  Positive Results from PulseSight’s Phase I Clinical Trial of PST-611 in Dry AMD/Geographic Atrophy Presented at ARVO 2026

  May 11, 2026

   · 

  5 min read
• Press Releases

  Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing

  May 11, 2026

   · 

  4 min read
• Press Releases

  Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay

  May 11, 2026

   · 

  2 min read
• Press Releases

  Bavarian Nordic – Completion of Share Buy-Back Program - May 11, 2026

  May 11, 2026

   · 

  2 min read
• Press Releases

  Kelyniam Global Announces Strong Q1 2026 Financial Results

  May 11, 2026

   · 

  2 min read
• Press Releases

  ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

  May 11, 2026

   · 

  4 min read
• Press Releases

  Certara Reports First Quarter 2026 Financial Results

  May 11, 2026

   · 

  23 min read
• Press Releases

  Partner Therapeutics Announces FDA Approval of BIZENGRI® (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner’s National Priority Voucher

  May 11, 2026

   · 

  12 min read